Wednesday, October 28, 2015 | ||||||
8:00 am | Registration and Breakfast | |||||
9:00 am | Chair’s Opening Remarks | |||||
9:10 am | Stakeholder Panel: The US Digital Health Leaders Forum The US market continues to take the lead in healthcare technology and innovation. As global technology corporations increase their activity within the space and whilst innovation and venture capital continues to grow in this market, stakeholders are becoming concerned with how healthcare facilities, regulations and professionals will be able to successfully uptake this technology and data. In order for an effective transition period to take place, the industry must first address the likely challenges to occur. The opening panel of leading stakeholder voices from US healthcare, life sciences, pharmaceuticals and technology providers will share their various perspectives on this inevitable transition.
Young K. Sohn, President and Chief Strategy Officer, Samsung Electronics
Andrew Thompson, CEO, Proteus Digital Health
| |||||
10:00 am | CMO Panel: Forecasting Future Healthcare Delivery in the USA As healthcare becomes more unaffordable and technology continues to capture public imagination, new healthcare delivery models are starting to take shape. The whole future delivery system for healthcare is undergoing change and this is due to technology and digital data. This panel, featuring industry-leading Chief Medical Officers, will determine the future impact of data and technology when it comes to everyday health care practices.
Andrew Racine, Senior Vice President and Chief Medical Officer, Montefiore Medical Center and Executive Director, Montefiore Medical Group
| |||||
10:50 am | Networking Break | |||||
11:20 am | Keynote Interview: The Merger of Medicine, Healthcare and Technology | |||||
11:40 am | Investment Panel: Attracting the Full Range of Investment Formats for Digital Health Development As larger corporations move into the sector and digital data continues to gather pace, it is highly likely that the digital health industry will now start to scale up. Will companies finally be able to crack this market and accelerate growth? If they are then investors will need to play a key role in order to make sure that this growth is scalable and commercial. There has been much start-up innovation in this sector, particularly in the US where venture capitalists have played significant roles in helping digital health technologies catch the consumer eye but what would the impact be when private equity and investment bankers join the game?
| |||||
12:30 pm | Panel: Commercializing Digital Health Innovation Through Best Practice Business Models Digital health innovation in the US continues to grow but attention needs to be paid on the business models required based on reimbursement in accordance with the value they bring to public healthcare. In some cases, the business model and reimbursement will be based upon finding ways of effectively driving down costs in the healthcare system, often working in collaboration with key regulatory figures.
Halle Tecco, Founder and Managing Director, Rock Health
Michael Laskoff, CEO, Abilto
| |||||
1:20 pm | Networking Lunch | |||||
2:20 pm | Regulation Panel: What Role Will IT Play in US Healthcare Reforms? Seismic changes have been going on in the US due to the creation of the Affordable Care Act as well as increased cost pressures. In light of the aid that digital health can bring towards this economically, it will inevitably bring with it a whole host of regulatory implications. Forecasting what these implications will be when healthcare migrates onto consumer digital devices will be critical for the effective transition of healthcare services. For example a smart phone can monitor a large range of health conditions but if, due to digital transformation, it turns into a medical device, is it not therefore subject to regulation?
| |||||
3:10 pm | Innovation Panel: Identifying Technological Success Stories and the Implementation Strategies They Require From smart pills to 3D bioprinting, to digestible and wearable sensors to nanorobotics and next generation gene sequencing and beyond, the vast array of technologies under development has the potential to completely transform health and medicine.
Babak Parviz, Vice President, Amazon
Jon Zimmerman, Global Chief Technology Officer and General Manager for Clinical Business Solutions, GE Healthcare
Nancy Green, Managing Principal – Healthcare Innovations, Verizon
| |||||
4:00 pm | Keynote Interview The health sector has been slow compared to other industries in embracing the digital opportunity. Featuring an in-depth Q&A session between an FT journalist and a CEO of a retail, banking or travel organisation, what can the health industry learn in terms of expected barriers and how to overcome them? | |||||
4:20 pm | Chair’s Closing Remarks | |||||
4:30 pm | Networking Drinks Reception |